DS Daily - 16th April 2010 |
 |
Mephedrone ban shows how politics contaminate science, says Lancet
A ban on the drug mephedrone brought in by the Government this month was a rushed decision that further exemplifies how politics is “contaminating” science and the work of government advisers, according to a leading medical journal [Times, UK]
Cannabis conversations
This week Duncan Jarvies discusses with London GP Chris Ford how to talk to patients about their cannabis use [BMJ Podcast, UK]
Effective Community Treatment for Drug Misusers
Outcome Monitoring an Independent Review Dr John Marsden and Garry Stillwell - Press release [Blenheim CDP, UK]
Low opiate overdose rate on naltrexone implants
Short-acting opiate blockers are associated with high overdose rates. A product intended to block opiates for six months can overcome that problem, though patients may resort to sedatives instead. Print publication 2006 [Drug and Alcohol Findings, UK]
Free Substance Abuse Treatment
According to the 2008 National Survey on Drug Use and Health, the most common reason why individuals with substance use problems do not seek treatment is the financial burden imposed by a lack of health insurance [SAMHSA, USA]
Addiction Treatment Forum
Volume 20 Spring 2010 [ATF, USA]
Service Delivery for People with Co-existing Mental Health and Addiction Problems - Integrated Solutions 2010
This service delivery guidance document provides advice to assist mental health and addiction services to enable the provision of more integrated care for people with co-existing mental health and addiction problems [Ministry of Health, New Zealand]
Te Ariari o te Oranga: The Assessment and Management of People with Co-existing Mental Health and Substance Use Problems 2010
The publication presents a clinical framework to assist health professionals working with co-existing substance use and mental health problems [Ministry of Health, New Zealand]
Drug World News
Issue for April [Paul Cook]